 |
|
Welcome to the homepage of DR. RIETHMÜLLER M/R/S GMBH located in Frankfurt, Germany.
DR. RIETHMÜLLER M/R/S GMBH are international consultants for the development, evaluation,
registration and marketing of medicines, medical devices and diagnostics.
DR. RIETHMÜLLER M/R/S GmbH offers tailor - made solutions for a faster return on investment. On the
strength of our long-standing success, in-depth knowledge and experience in drug development in the
pharmaceutical industry, we provide straightforward strategies, know-how and services in the
development, registration and marketing of medications, emphasizing the outstanding features of
your products. We successfully performed international Phase I – IV clinical studies in various
indications and achieved numerous national and international registrations (EMEA, MRP, FDA, Japan)
of innovative and generic drugs in the shortest possible time as well as orphan drug designations.
Our core activities comprise:
Clinical development, marketing, preparation of registrational dossiers, medical writing, Orphan Drug Designations.
Preclinical development:
consulting in pharmacology, pharmaceutical development, toxicology, preparation of
registrational files.
Please feel free to contact us should you require any information
in addition to that presented on our homepage.
 Mission and advantages
Consulting and services
Get in touch with us!
Public Affairs Information:
| 09 Dec 2015 BPI Position Paper 2015 | | Position paper of BPI on Orphan Drugs: Dr. Hilde Riethmüller-Winzen was involved to prepare this document. (German language) |
|
|
|
